Search Results - "Mukhametshina, Guzel Z"

Randomized double-blind clinical trial comparing safety and efficacy of the biosimilar BCD-022 with reference trastuzumab by Alexeev, Sergey M, Khorinko, Andrey V, Mukhametshina, Guzel Z, Shelepen, Konstantin G, Burdaeva, Olga N, Kulik, Sergey A, Satheesh, Chiradoni Thugappa, Srivastava, Kirti, Vikranth, Mummaneni, Kryukov, Fedor, Paltusova, Anastasia N, Shustova, Mariya S, Ivanov, Roman A

“…BCD-022 is a trastuzumab biosimilar which was shown to be equivalent to reference trastuzumab in a wide panel of physicochemical studies as well as preclinical…”
Get full text

Afatinib in EGFR TKI-naïve patients with locally advanced or metastatic EGFR mutation-positive non-small cell lung cancer: Interim analysis of a Phase 3b study by de Marinis, Filippo, Laktionov, Konstantin K., Poltoratskiy, Artem, Egorova, Inna, Hochmair, Maximilian, Passaro, Antonio, Migliorino, Maria Rita, Metro, Giulio, Gottfried, Maya, Tsoi, Daphne, Ostoros, Gyula, Rizzato, Simona, Mukhametshina, Guzel Z., Schumacher, Michael, Novello, Silvia, Dziadziuszko, Rafal, Tang, Wenbo, Clementi, Laura, Cseh, Agnieszka, Kowalski, Dariusz

“…•Interim data from a Phase 3b trial investigating afatinib in a real-world setting.•TKI-naïve patients with EGFRm + NSCLC received afatinib 40 mg orally,…”
Get full text

Efficacy and safety of nurulimab+prolgolimab with continued prolgolimab therapy compared to prolgolimab alone as first-line therapy in patients with unresectable or metastatic melanoma: final results of the phase II OBERTON clinical study by Samoylenko, Igor V., Demidov, Lev V., Moiseenko, Fedor V., Dvorkin, Mikhail V., Demidova, Svetlana A., Protsenko, Svetlana A., Stroyakovskiy, Daniil L., Kozlov, Vadim V., Odintsova, Svetlana V., Kirtbaya, Dmitry V., Tantsyrev, Denis A., Mochalova, Anastasia S., Orlova, Rashida V., Mukhametshina, Guzel Z., Fadeeva, Natalia V., Fomin, Evgeny A., Chapko, Yana S., Tarasova, Anna V., Ermakov, Nikolay B., Shemerovskiy, Alexander K., Vaschenko, Vera A., Chistyakov, Valery M., Zinkina-Orikhan, Arina V., Lin'kova, Yulia N., Kryukov, Fedor B., Sorokina, Irina V., Siliutina, Anna A.

“…Background. In an era of breakthroughs in cancer immunotherapy, CheckMate 067 studies declared the combination of PD-1 and CTLA-4 inhibitors a new standard of…”
Get full text

The efficacy of the combination of eribulin and trastuzumab in advanced HER2-positive breast cancer: the results of Russian observational study by Kovalenko, Elena I., Artamonova, Elena V., Karabina, Elena V., Andreiashkina, Irina I., Prokof’eva, Ekaterina A., Popova, Nataliia O., Gaisina, Elena A., Evstigneeva, Irina V., Shaidorov, Mikhail V., Zhiliaeva, Larisa A., Ponomarenko, Dmitrii M., Khasanova, Alfiia I., Mukhametshina, Guzel Z., Koziakov, Anton E., Vorotilina, Liudmila V., Povyshev, Anton Iu, Simolina, Elena I., Marfutov, Vasilii V., Kozlov, Dmitrii V., Suslova, Irina R., Shikina, Valentina E., Karandeeva, Tatiana V., Shepel’, Artem O., Kramskaia, Liudmila V., Oskirko, Denis A., Frolova, Olga S.

“…The article presents the experience of 19 Russian medical institutions on the use of eribulin in combination with trastuzumab in various treatment lines of…”
Get full text

Eribulin-trastuzumab combination in HER2-positive metastatic breast cancer: updated results from a Russian observational study by Kovalenko, E. I., Artamonova, E. V., Bolotina, L. V., Zhiliaeva, L. A., Ponomarenko, D. M., Karabina, E. V., Mukhametshina, G. Z., Khasanova, A. I., Ratner, E. Yu, Safarova, A. R., Manikhas, A. G., Popova, N. O., Evstigneeva, I. V., Vladimirova, L. Yu, Kramskaya, L. V., Karandeeva, T. V., Suslova, I. R., Romanchuk, O. V., Shikina, V. E., Povyshev, A. Yu, Osipov, M. A., Cherniakova, E. M., Dergunov, A. S., Volkonskiy, M. V., Chernov, I. S., Shumskaya, I. E., Fael, M. M., Garifullina, V. I., Gudkova, I. E.

“…Introduction . The standard of 1st line treatment of HER2+ metastatic breast cancer (mBC) is double blockade with trastuzumab and pertuzumab + taxane, 2nd…”
Get full text

The potential of using eribulin in patients with breast cancer, associated with brain metastasis: the scientific background and the Russian clinical experience by Kolyadina, Irina V, Bulavina, Irina S, Petkau, Vladislav V, Strakhova, Natalia V, Gorbunova, Vera A, Kovalenko, Elena I, Manziuk, Liudmila V, Artamonova, Elena V, Zhukova, Liudmila G, Bolotina, Larisa V, Gan'shina, Inna P, Semiglazova, Tatiana Iu, Manikhas, Aleksei G, Raevskaia, Natalia A, Itkin, Ilia M, Khokhlova, Svetlana V, Filonenko, Dmitrii V, Gol'dberg, Viktor E, Popova, Natalia O, Ponomarenko, Dmitrii M, Shikina, Valentina E, Vladimirova, Liubov I, Tikhanovskaia, Natalia M, Karabina, Elena V, Mukhametshina, Guzel Z, Khasanova, Alfiia I, Safina, Sufiia Z, Shaidorov, Mikhail V, Orlov, Andrei E, Kostalanova, Iuliia V, Levchenko, Natalia V, Osipov, Mikhail A, Karandeeva, Tatiana V, Evstigneeva, Irina V, Chernov, Igor S, Kolokolov, Dzheims Dzh, Povyshev, Anton Iu, Shatokhina, Alina S, Cherniakova, Elena M, Shkodenko, Oksana N, Kuz'mina, Evgeniia S

“…Aim. Eribulin is an active cytostatic, associated with a wide range of mechanisms of antitumor effects, but eribulin efficiency and safety in patients with…”
Get full text

Efficacy and safety of eribulin in HER2-negative metastatic breast cancer: the results of long-term experience in real clinical practice in Russia by Gorbunova, Vera A, Kolyadina, Irina V, Kovalenko, Elena I, Manziuk, Liudmila V, Artamonova, Elena V, Zhukova, Liudmila G, Bolotina, Larisa V, Semiglazova, Tat'iana Iu, Manikhas, Aleksei G, Raevskaia, Natal'ia A, Itkin, Il'ia M, Filonenko, Dmitrii V, Zhilyaeva, Larisa A, Gol'dberg, Viktor E, Popova, Natal'ia O, Ponomarenko, Dmitrii M, Shikina, Valentina E, Suslova, Irina R, Romanchuk, Olga V, Kozlov, Dmitrii V, Rzaev, Ali-Dzarakhmat S, Marfutov, Vasilii V, Andreiashkina, Irina I, Vladimirova, Liubov' I, Mitashok, Irina S, Tikhanovskaia, Natal'ia M, Karabina, Elena V, Mukhametshina, Guzel' Z, Khasanova, Al'fiia I, Safina, Sufiia Z, Shaidorov, Mikhail V, Morozov, Dmitrii A, Prokof'eva, Elena P, Kramskaia, Liudmila V, Karandeeva, Tat'iana V, Evstigneeva, Irina V, Ovchinnikova, Elena G, Klement'eva, Tat'iana P, Khrupalo, Olga V, Tiuvinova, Elena V, Sherstnev, Viktor M, Chernov, Igor' S, Kolokolov, Dzheims Dzh, Gaisina, Elena A, Levchenko, Natal'ia V, Chubenko, Viacheslav A, Povyshev, Anton Iu, Iudina, Inna V, Vorotilina, Liudmila V, Andreeva, Tat'iana V, Tumanian, Garnik S, Koziakov, Anton E, Gil'mutdinova, Liudmila A, Osipov, Mikhail A, Shatokhina, Alina S, Vazhenina, Alena A, Chichkanova, Angelina S, Vladimirov, Vladimir I, Ivanov, Aleksandr N, Belokhvostova, Anna S, Cherniakova, Elena M, Tul'china, Elena A, Maklashova, Svetlana A, Shkodenko, Oksana N, Kostalanova, Iuliia V, Tarasova, Anna V, Kuz'mina, Evgeniia S

“…Aim. The aim of the study is to examine the efficacy and safety of eribulin in HER2-negative metastatic breast cancer (BC) in Russian clinical practice…”
Get full text